NCT02784236View on ClinicalTrials.gov

INTEGRATED IMPACT ASSESSMENT a Telemedicine Program in the Care of Patients With Diabetes Mellitus Type 1 Intensive Treatment With Multiple Daily Injections.

NACompletedINTERVENTIONAL

Enrollment

121

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

September 30, 2016

Conditions

Metabolic Impact

Interventions

DEVICE

telemedicine

The study population corresponds to patients\> 18 and \<65 years with DM1 of\> 1 year of evolution, and treated with MDI HbA1c\> 7%. It is changing one group of subjects between two observation times due to any intervention in this case the addition of a tele

Trial Locations (1)

29010

FIMABIS, Málaga

All Listed Sponsors

lead

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud

OTHER

NCT02784236 - INTEGRATED IMPACT ASSESSMENT a Telemedicine Program in the Care of Patients With Diabetes Mellitus Type 1 Intensive Treatment With Multiple Daily Injections. | Biotech Hunter | Biotech Hunter